Q4 2024 |
55 |
$2.5B |
+$330M |
-$372M |
-$42.6M |
APLS, ZYME, CRNX, JAZZ, PRTA
|
13F-HR |
2/14/2025, 01:05 PM |
Q3 2024 |
63 |
$2.92B |
+$255M |
-$670M |
-$415M |
APLS, ANAB, CRNX, PRTA, JAZZ
|
13F-HR |
11/14/2024, 11:16 AM |
Q2 2024 |
55 |
$3.27B |
+$258M |
-$257M |
+$277K |
APLS, PRTA, SRPT, ANAB, CRNX
|
13F-HR |
8/14/2024, 11:37 AM |
Q1 2024 |
52 |
$3.85B |
+$679M |
-$647M |
+$32.1M |
APLS, PRTA, ARVN, SRPT, CRNX
|
13F-HR |
5/15/2024, 11:45 AM |
Q4 2023 |
47 |
$3.85B |
+$651M |
-$366M |
+$284M |
APLS, MRTX, PRTA, ARVN, GLPG
|
13F-HR |
2/14/2024, 11:30 AM |
Q3 2023 |
60 |
$2.96B |
+$677M |
-$947M |
-$270M |
PRTA, APLS, MRTX, GLPG, RVMD
|
13F-HR |
11/14/2023, 12:16 PM |
Q2 2023 |
64 |
$4.08B |
+$719M |
-$152M |
+$566M |
PRTA, APLS, SRPT, JNJ, GLPG
|
13F-HR |
8/14/2023, 12:42 PM |
Q1 2023 |
53 |
$3.1B |
+$163M |
-$38.6M |
+$125M |
PRTA, SRPT, APLS, GLPG, ANAB
|
13F-HR |
5/15/2023, 12:19 PM |
Q4 2022 |
61 |
$3.28B |
+$298M |
-$31.2M |
+$267M |
PRTA, SRPT, APLS, ANAB, GLPG
|
13F-HR |
2/14/2023, 11:00 AM |
Q3 2022 |
70 |
$3.38B |
+$315M |
-$343M |
-$27.9M |
PRTA, APLS, SRPT, ANAB, ARVN
|
13F-HR |
11/14/2022, 10:07 AM |
Q2 2022 |
74 |
$2.89B |
+$561M |
-$18.1M |
+$543M |
PRTA, APLS, SRPT, SGEN, GLPG
|
13F-HR |
8/15/2022, 11:14 AM |
Q1 2022 |
82 |
$3.19B |
+$1.13B |
-$197M |
+$937M |
PRTA, APLS, GLPG, ANAB, SRPT
|
13F-HR |
5/16/2022, 09:42 AM |
Q4 2021 |
70 |
$3.13B |
+$760M |
-$24.5M |
+$735M |
PRTA, ANAB, RCUS, XNCR, APLS
|
13F-HR |
2/14/2022, 08:56 AM |
Q3 2021 |
63 |
$2.83B |
+$362M |
-$330M |
+$32.9M |
PRTA, MORF, ANAB, RCUS, XNCR
|
Restatement |
11/22/2021, 01:52 PM |
Q2 2021 |
67 |
$2.66B |
+$403M |
-$61.5M |
+$342M |
PRTA, MORF, ANAB, XNCR, RLAY
|
13F-HR |
8/16/2021, 11:11 AM |
Q1 2021 |
65 |
$2.23B |
+$556M |
-$153M |
+$403M |
PRTA, XNCR, MORF, ANAB, NUVB
|
13F-HR |
5/17/2021, 10:53 AM |
Q4 2020 |
64 |
$1.86B |
+$577M |
-$203M |
+$374M |
XNCR, RLAY, STTK, SPRY, PRTA
|
13F-HR |
2/16/2021, 09:30 AM |
Q3 2020 |
48 |
$1.4B |
+$334M |
-$24.3M |
+$310M |
XNCR, KURA, RLAY, PRTA, MORF
|
13F-HR |
11/16/2020, 09:47 AM |
Q2 2020 |
48 |
$1.35B |
+$576M |
-$118M |
+$457M |
XNCR, PRTA, ORIC, MORF, KURA
|
13F-HR |
8/14/2020, 10:59 AM |
Q1 2020 |
51 |
$957M |
+$244M |
-$71.3M |
+$172M |
PRTA, XNCR, ARVN, DRNA, FATE
|
13F-HR |
5/15/2020, 04:07 PM |
Q4 2019 |
44 |
$1.11B |
+$363M |
-$90.3M |
+$272M |
PRTA, XNCR, DRNA, FGEN, KURA
|
Restatement |
2/18/2020, 03:31 PM |
Q3 2019 |
38 |
$792M |
+$199M |
-$112M |
+$86.9M |
XNCR, PRTA, ONCE, KURA, ARGX
|
13F-HR |
11/14/2019, 03:15 PM |
Q2 2019 |
39 |
$990M |
+$250M |
-$106M |
+$144M |
KURA, XNCR, ARGX, CRSP, FGEN
|
13F-HR |
8/14/2019, 04:49 PM |
Q1 2019 |
41 |
$1.08B |
+$314M |
-$291M |
+$22.9M |
ARGX, KURA, MRTX, CRSP, XNCR
|
13F-HR |
5/15/2019, 04:21 PM |
Q4 2018 |
53 |
$999M |
+$396M |
-$118M |
+$278M |
ARGX, KURA, FGEN, IRWD, ASMB
|
13F-HR |
2/14/2019, 03:15 PM |
Q3 2018 |
50 |
$1.11B |
+$254M |
-$174M |
+$80.1M |
FGEN, ASMB, IRWD, ASND, KURA
|
13F-HR |
11/14/2018, 03:53 PM |
Q2 2018 |
33 |
$1.05B |
+$319M |
-$90.8M |
+$228M |
FGEN, IRWD, ASMB, ASND, KURA
|
13F-HR |
8/14/2018, 12:11 PM |
Q1 2018 |
31 |
$997M |
+$195M |
-$75.2M |
+$120M |
ASMB, ASND, FGEN, IRWD, KURA
|
13F-HR |
5/15/2018, 04:07 PM |
Q4 2017 |
30 |
$888M |
+$326M |
-$17.4M |
+$308M |
ASMB, FGEN, IRWD, ASND, KURA
|
13F-HR |
2/14/2018, 12:50 PM |
Q3 2017 |
39 |
$750M |
+$278M |
-$74.3M |
+$203M |
ASMB, FGEN, IRWD, ASND, KURA
|
13F-HR |
11/14/2017, 03:25 PM |
Q2 2017 |
36 |
$563M |
+$256M |
-$18.6M |
+$237M |
IRWD, ASMB, FGEN, GLPG, ASND
|
13F-HR |
8/14/2017, 04:25 PM |
Q1 2017 |
32 |
$395M |
+$113M |
-$23.6M |
+$89.3M |
ASMB, IRWD, GLPG, ASND, KURA
|
Restatement |
5/19/2017, 12:39 PM |
Q4 2016 |
0 |
|
|
|
|
|
New Holdings |
2/15/2017, 03:59 PM |
Q4 2016 |
30 |
$299M |
+$109M |
-$38.1M |
+$70.8M |
IRWD, GLPG, ASMB, ALXN, ASND
|
Restatement |
2/15/2017, 03:56 PM |
Q3 2016 |
31 |
$326M |
+$131M |
-$21.1M |
+$110M |
IRWD, GLPG, ASMB, DERM, ARDX
|
13F-HR |
11/14/2016, 03:34 PM |
Q2 2016 |
32 |
$254M |
+$79.2M |
-$21.2M |
+$58.1M |
IRWD, GLPG, RTRX, CYTK, ASMB
|
13F-HR |
8/15/2016, 12:02 PM |
Q1 2016 |
36 |
$285M |
+$137M |
-$23.8M |
+$113M |
IRWD, FPRX, EPZM, FGEN, RTRX
|
13F-HR |
5/16/2016, 04:14 PM |
Q4 2015 |
31 |
$318M |
+$141M |
-$21.6B |
-$21.5B |
FGEN, FPRX, RTRX, KURA, ASMB
|
13F-HR |
2/16/2016, 09:48 AM |
Q3 2015 |
25 |
$220M |
+$42.4M |
-$12M |
+$30.4M |
FGEN, ATRA, RTRX, EPZM, ASMB
|
13F-HR |
11/16/2015, 10:51 AM |
Q2 2015 |
25 |
$300M |
+$77.8M |
-$3.97M |
+$73.8M |
ATRA, EPZM, ASMB, FGEN, KITE
|
13F-HR |
8/14/2015, 10:30 AM |
Q1 2015 |
22 |
$292M |
+$118M |
-$203M |
-$85.7M |
ATRA, EPZM, RCPT, ASMB, CLVSQ
|
Restatement |
5/15/2015, 06:27 PM |
Q4 2014 |
21 |
$189M |
|
|
|
KITE, CLVSQ, RCPT, MGNX, IRWD
|
13F-HR |
2/17/2015, 03:13 PM |